QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

Corporate Breaking News

Home : QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

Dec 07 2021	QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND
CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced the presentation of...


Source:https://www.prnewswire.com:443/news-releases/quralis-presents-new-data-confirming-role-of-stathmin-2-in-neuronal-disease-biology-at-32nd-international-symposium-on-alsmnd-301437449.html

Related News
» GemUni launches a Decentralized Universe of Casual Games advised by Angry Birds' co-creator » Court Approves Entry into Exit Financing Commitment Letters and Sets Date for Confirmation Plan Hearing